Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis

[1]  M. Okano,et al.  Cohort Study , 2020, Definitions.

[2]  R. Yeh,et al.  The Hospital Readmissions Reduction Program - Time for a Reboot. , 2019, The New England journal of medicine.

[3]  M. DeBaun,et al.  Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study , 2018, Hematology.

[4]  V. Gordeuk,et al.  High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease , 2018, American journal of hematology.

[5]  J. Saltzman,et al.  Thirty-Day Readmission Among Patients With Non-Variceal Upper Gastrointestinal Hemorrhage and Effects on Outcomes. , 2018, Gastroenterology.

[6]  P. Tanabe,et al.  Emergency Department (ED), ED Observation, Day Hospital, and Hospital Admissions for Adults with Sickle Cell Disease , 2018, The western journal of emergency medicine.

[7]  M. L. Rinke,et al.  Decreased Hospital Readmissions for Vaso Occlusive Crisis with Implementation of a Sickle Cell Pain Action Plan (SPAP) , 2017 .

[8]  Katelin A Mirkin,et al.  Risk factors for 30‐day readmission in patients with congestive heart failure , 2017, Heart & lung : the journal of critical care.

[9]  M. DeBaun,et al.  Risk Factors for 30-Day Readmission in Adults with Sickle Cell Disease. , 2017, The American journal of medicine.

[10]  A. Fernandes,et al.  Hospitalizations of children with sickle cell disease in the Brazilian Unified Health System in the state of Minas Gerais. , 2017, Jornal de pediatria.

[11]  R. Liem,et al.  Opioid prescription practices at discharge and 30‐day returns in children with sickle cell disease and pain , 2015, Pediatric blood & cancer.

[12]  R. Bartley,et al.  Aiming to Reduce Admissions and Also Re-Admissions in Pediatric Sickle Cell Disease: A Single Institutional Experience with Six Interventions , 2016 .

[13]  M. Beach,et al.  Improving Emergency Providers' Attitudes Toward Sickle Cell Patients in Pain. , 2016, Journal of pain and symptom management.

[14]  Roger B. Davis,et al.  Differences Between Early and Late Readmissions Among Patients , 2015, Annals of Internal Medicine.

[15]  Leora I. Horwitz,et al.  Association of hospital volume with readmission rates: a retrospective cross-sectional study , 2015, BMJ : British Medical Journal.

[16]  Steven J. Choi,et al.  Reducing Health Care Utilization in Sickle Cell Disease Patients By Implementation of an Individualized, Multimodal Care Plan during Hospital Admission and at Inpatient to Outpatient Discharge , 2014 .

[17]  L. Horwitz.  The insurance-readmission paradox: why increasing insurance coverage may not reduce hospital-level readmission rates. , 2014, Journal of hospital medicine.

[18]  William J Savage,et al.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. , 2014, JAMA.

[19]  Michael R Gionfriddo,et al.  Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. , 2014, JAMA internal medicine.

[20]  A. Majeed,et al.  Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: observational study. , 2013, Journal of public health.

[21]  Donna J Cartwright,et al.  ICD-9-CM to ICD-10-CM Codes: What? Why? How? , 2013, Advances in wound care.

[22]  K. Noohi,et al.  Reasons for Discharge against Medical Advice: A Case Study of Emergency Departments in Iran , 2013, International journal of health policy and management.

[23]  Eric Rollins,et al.  Medicare readmission rates showed meaningful decline in 2012. , 2013, Medicare & medicaid research review.

[24]  Leora I. Horwitz,et al.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.

[25]  Harlan M Krumholz,et al.  Post-hospital syndrome--an acquired, transient condition of generalized risk. , 2013, The New England journal of medicine.

[26]  J. Feinglass,et al.  Sickle cell disease patients' perceptions of emergency department pain management. , 2012, Journal of the National Medical Association.

[27]  Mark Nimmer,et al.  Outpatient follow‐up and rehospitalizations for sickle cell disease patients , 2012, Pediatric blood & cancer.

[28]  J. Elander,et al.  Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice , 2011, Ethnicity & health.

[29]  E. Neufeld,et al.  Transition from pediatric to adult care for sickle cell disease: Results of a survey of pediatric providers , 2011, American journal of hematology.

[30]  N. Ratanawongsa,et al.  Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care. , 2010, Journal of hospital medicine.

[31]  Pamela L Owens,et al.  Acute care utilization and rehospitalizations for sickle cell disease. , 2010, JAMA.

[32]  K. Hassell.  Population estimates of sickle cell disease in the U.S. , 2010, American journal of preventive medicine.

[33]  Mark V. Williams,et al.  Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.

[34]  S. Ballas.  The cost of health care for patients with sickle cell disease , 2009, American journal of hematology.

[35]  A. Hartzema,et al.  The cost of health care for children and adults with sickle cell disease , 2009, American journal of hematology.

[36]  J. Field,et al.  Risk factors for hospital readmission within 30 days: A new quality measure for children with sickle cell disease , 2009, Pediatric blood & cancer.

[37]  Douglas McCarthy,et al.  Why Not the Best? Results from the National Scorecard on U.S. Health System Performance, 2011 , 2006 .

[38]  É. Labbé,et al.  Physicians’ Attitude and Practices in Sickle Cell Disease Pain Management , 2005, Journal of palliative care.

[39]  S. Ballas,et al.  Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance , 2005, American journal of hematology.

[40]  J. Lusher,et al.  Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. , 2004, Journal of pain and symptom management.

[41]  C. Pegelow,et al.  Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. , 2003, JAMA.

[42]  C. Klabunde,et al.  Assessing Comorbidity Using Claims Data: An Overview , 2002, Medical care.

[43]  L. Benjamin,et al.  Sickle cell-related pain: perceptions of medical practitioners. , 1997, Journal of pain and symptom management.

[44]  M. Yin,et al.  “Against Medical Advice” Discharges Among HIV‐Infected Patients: Health and Health Services Outcomes , 2017, The Journal of the Association of Nurses in AIDS Care : JANAC.

[45]  K. A. Holmes,et al.  Results of a National Survey , 2016 .

[46]  K. Jaaback.  A Systematic Review and Meta-Analysis of Randomized Trials , 2007 .

[47]  M. Baskin,et al.  Transition to adult care for adolescents with sickle cell disease: Results of a national survey , 2004, International journal of adolescent medicine and health.